TARGET AUDIENCE The primary target audiences for this initial education include health care providers (physicians, nurse practitioners, and PAs) specializing in hematology, cardiology, neurology, and nephrology. PROGRAM OVERVIEW The aim of this educational program is to enhance clinicians’ knowledge and confidence about new assays for FXI/FXIa inhibitor therapies. Learning Objectives Summarize key features of the different categories of FXI/XIa inhibitors Compare the key aspects of current FXI/XIa inhibitors in clinical trials, including potential implications of the most recent findings
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- Chandler Building
Pricing
CME included with membership
| Non-member – Pharmacy SIG Journal Club (per session) | $35 |
| Member – Pharmacy SIG Journal Club (per session) | Free |
| Non-member – 2025 Fundamentals of HCT eBook | $400 |
| Member – 2025 Fundamentals of HCT eBook | $200 |
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Hematology
- Medical Oncology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Ophthalmology
- Pediatric Neurology
- Pulmonary Disease
- Rheumatology
- Transplant Surgery
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $35–400
This provider prices CME through membership. Individual courses may also be sold separately.
See plans on academy.isth.orgListed by the provider
- Case-based learning
- Credit · Up to 1 credit
- Membership pricing
- Commercial Support
-
ReleasedNov 1, 2025
-
Last day to claim creditMar 1, 2027 5 months left
-
International Society on Thrombosis and Haemostasis +1 Measuring Up: The Need for New Assays for FXI/FXIa Inhibitor Therapies
-
International Society on Thrombosis and Haemostasis +1 Evaluating the potential of factor XI/factor XIa inhibitors to address unmet anticoagulation needs in critical patient populations
-
International Society on Thrombosis and Haemostasis +1 Emerging Therapies in Thrombosis: Factor XI/XIa Inhibitors: Learning More: FXI/XIa Inhibitor Trials
